Table 1.
Effector mechanisms in immune restoration disease
Pathogen | Immunopathology | Effector cells and cytokines | References |
---|---|---|---|
Bacteria | |||
Mycobacterium tuberculosis (MTB) |
Lymphadenopathy, pulmonary manifestations, systemic inflammatory responses etc. |
CD4 T cells, macrophages?, Tregs?, LPS? |
[11,15–19,20•] |
Mycobacterium avium complex (MAC) |
Lymphadenitis, pulmonary granulomatous responses |
CD4 T cells? | [21,22] |
Mycobacterium leprae | Borderline disease and type 1 reactions | CD4 T cells? | [23] |
Other mycobacteria | Lymphadenopathy, pulmonary manifestations, | CD4 T cells? | [24] |
Viruses | |||
Herpes simplex virus (HSV) | Dermatological manifestations | CD8 T cells, IL-6 | [25,26] |
Varicella zoster virus (VZV) | Dermatological manifestations | CD8 & CD4 T cells | [27,28] |
Human herpes virus 8 (HHV-8) | Kaposi sarcoma flare | CD8 T cells?, IFN-γ, TNF-α | [29–32] |
Cytomegalovirus (CMV) | CMV retinitis, immune recovery uveitis | CD8 T cells, NK cells, CD4 cells (IFN-γ), IL-6 (macrophages), IL-12, Treg deficiency? |
[14,33–37] |
Hepatitis B virus (HBV) | Inflammatory flares and elevated liver enzymes | CD8 T cells, Tregs? | [2,38] |
Hepatitis C virus (HCV) | Inflammatory flares and elevated liver enzymes | T cells, cytokines, Tregs? | [38,39] |
JC virus (JCV) | Progressive multifocal leukoencephalopathy (PML) | CD8 T cells | [40–43] |
Fungi | |||
Cryptococcus neoformans | Central nervous system cryptococcosis | CD4 T cells, IFN-γ, macrophages | [44–46] |
Pneumocystis carinii | Pneumonia | CD8 T cells, CD4 T (Th2), IL-4, IL-5, IL-6 |
[47,48] |
Parasites | |||
Leishmania spp. | Visceral, cutaneous and mucosal leishmaniasis, post kala-azar dermal leishmaniasis |
CD4 T cells and IFN-γ?, macrophages? | [49] |
Schistosoma mansoni | Colitis and polyposis, granuloma formation around eggs |
CD4 T cells? | [50,51] |
IL, interleukin; LPS, lipopolysaccharide; NK, natural killer; Th2, T helper type 2; TNF, tumour necrosis factor; Tregs, regulatory T cells.